Intelligence Β· Clinical Pipeline

Compass Therapeutics Pipeline

All ClinicalTrials.gov programs at Compass Therapeutics β€” phase, modality, and trial IDs.

Programs
4

Quick answer

Compass Therapeutics has 4 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. COMP360 psilocybin

    Compass Therapeutics

    PTSD - Post Traumatic Stress Disorder

    phase 3 small molecule active

    1 trial
  2. CTX-009

    Compass Therapeutics

    Biliary Tract Cancer

    phase 3 small molecule active

    1 trial
  3. Psilocybin

    Compass Therapeutics

    Major Depressive Disorder

    phase 3 small molecule active

    2 trials
  4. Psilocybin

    Compass Therapeutics

    Treatment Resistant Depression

    phase 3 small molecule active

    7 trials

Frequently asked questions

How many pipeline programs does Compass Therapeutics have?

4 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources Β· All pipeline programs